Fetal anesthesia mystery: tiny study aims to make surgery safer for unborn babies
NCT ID NCT07571811
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will measure how three common anesthesia drugs—fentanyl, rocuronium, and atropine—behave in fetuses during maternal-fetal surgery. Researchers will analyze discarded fetal blood samples and track heart rate and movement to understand drug effects. The goal is to create safer, evidence-based dosing guidelines for fetal anesthesia. The study involves 10 pregnant women and does not change standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- fentanyl, rocuronium, and atropine
- What this could lead to
- If successful, this could lead to safer, more precise anesthesia dosing for fetuses during surgery, tailored to their age and size.
- What could go wrong
- This is a very small observational study (10 participants) that does not test a new treatment. It only measures drug levels in discarded blood samples, so it may not directly change care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FETAL ANESTHESIA are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States